Beta Bionics (BBNX) EPS (Basic) (2024 - 2026)

Beta Bionics has disclosed EPS (Basic) across 3 years of filings, most recently posting -$0.49 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at -$0.49, up 47.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 (up 80.0% YoY), and the FY2025 annual result was -$1.81, up 78.95% from the prior year.
• EPS (Basic) came in at -$0.49 for Q1 2026 at Beta Bionics, down from -$0.29 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of -$0.29 in Q4 2025 to a low of -$2.74 in Q4 2024.
• The 3-year median for EPS (Basic) is -$0.93 (2025), against an average of -$1.23.
• Across the five-year window, EPS (Basic) jumped 89.42% in 2025 and jumped 47.31% in 2026, its largest moves.
• Beta Bionics' EPS (Basic) stood at -$2.74 in 2024, then surged by 89.42% to -$0.29 in 2025, then sank by 68.97% to -$0.49 in 2026.
• The last three EPS (Basic) figures came in at -$0.49 (Q1 2026), -$0.29 (Q4 2025), and -$0.33 (Q3 2025), per Business Quant data.